NO944920L - Fremgangsmåte for å inhibere hirsutisme og alopecia hos kvinner - Google Patents

Fremgangsmåte for å inhibere hirsutisme og alopecia hos kvinner

Info

Publication number
NO944920L
NO944920L NO944920A NO944920A NO944920L NO 944920 L NO944920 L NO 944920L NO 944920 A NO944920 A NO 944920A NO 944920 A NO944920 A NO 944920A NO 944920 L NO944920 L NO 944920L
Authority
NO
Norway
Prior art keywords
alopecia
women
procedure
hirsutism
inhibiting
Prior art date
Application number
NO944920A
Other languages
English (en)
Other versions
NO944920D0 (no
Inventor
George Joseph Cullinan
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO944920D0 publication Critical patent/NO944920D0/no
Publication of NO944920L publication Critical patent/NO944920L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Det er beskrevet en fremgangsmåte for å Inhibere hirsutisme eller alopecia hos kvinner Innbefattende administrering til en kvinne som har behov for behandling av en effektiv mengde av en forbindelse som har formelen .OCHjCHi¿R2 (I) hvori R1 og R3 uavhengig av hverandre er hydrogen, O -CH3 O -C-(Ci-Cf, alkyl), eller -C-Ar, hvor Ar er eventuelt substituert fenyl; R2 er valgt fra gruppen bestående av pyrrolldlne, heksametylenamino og piperidlno; eller et farmasøytisk akseptabelt salt eller solvat derav.
NO944920A 1993-12-21 1994-12-19 Fremgangsmåte for å inhibere hirsutisme og alopecia hos kvinner NO944920L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/171,089 US5574048A (en) 1993-12-21 1993-12-21 Methods of inhibiting hirsutism and alopecia in women

Publications (2)

Publication Number Publication Date
NO944920D0 NO944920D0 (no) 1994-12-19
NO944920L true NO944920L (no) 1995-06-22

Family

ID=22622479

Family Applications (1)

Application Number Title Priority Date Filing Date
NO944920A NO944920L (no) 1993-12-21 1994-12-19 Fremgangsmåte for å inhibere hirsutisme og alopecia hos kvinner

Country Status (22)

Country Link
US (2) US5574048A (no)
EP (1) EP0659414B1 (no)
JP (1) JPH07215864A (no)
KR (1) KR950016728A (no)
CN (1) CN1107703A (no)
AT (1) ATE203406T1 (no)
AU (1) AU690162B2 (no)
CA (1) CA2138498A1 (no)
CZ (1) CZ321394A3 (no)
DE (1) DE69427807T2 (no)
DK (1) DK0659414T3 (no)
ES (1) ES2157961T3 (no)
GR (1) GR3036977T3 (no)
HU (1) HUT71479A (no)
IL (1) IL112040A0 (no)
NO (1) NO944920L (no)
NZ (1) NZ270171A (no)
PH (1) PH31440A (no)
PT (1) PT659414E (no)
RU (1) RU94044457A (no)
SI (1) SI0659414T1 (no)
ZA (1) ZA9410092B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965551A (en) 1996-02-21 1999-10-12 North Carolina State University Method of treating alopecia
TW442286B (en) * 1996-02-28 2001-06-23 Pfizer New therapeutic uses of estrogen agonists
IL120266A (en) 1996-02-28 2005-05-17 Pfizer Use of estrogen antagonists and estrogen agonists in the preparation of medicaments for inhibiting pathological conditions
KR20020013533A (ko) 1999-05-04 2002-02-20 앤드류 맥린 안드로겐 글리코사이드와 그것의 안드로겐 활성
US20060263452A1 (en) * 2005-05-17 2006-11-23 Alwyn Dowell Topical composition containing essential oils
WO2011014649A1 (en) 2009-07-29 2011-02-03 Duke University Compositions and methods for inhibiting hair growth

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4133814A (en) * 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
US4380635A (en) * 1981-04-03 1983-04-19 Eli Lilly And Company Synthesis of acylated benzothiophenes
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
US4859585A (en) * 1986-04-17 1989-08-22 Trustees Of Tufts College In-vitro methods for identifying compositions which are agonists and antagonists of estrogens
US5075321A (en) * 1987-03-24 1991-12-24 University Of Pennsylvania Methods of treating diseases characterized by interactions of IgG-containing immune complexes with macrophage Fc receptors using antiestrogenic benzothiophenes
US5395842A (en) * 1988-10-31 1995-03-07 Endorecherche Inc. Anti-estrogenic compounds and compositions
JP3157882B2 (ja) * 1991-11-15 2001-04-16 帝国臓器製薬株式会社 新規なベンゾチオフエン誘導体

Also Published As

Publication number Publication date
SI0659414T1 (en) 2001-12-31
EP0659414A3 (en) 1995-09-06
CA2138498A1 (en) 1995-06-22
PH31440A (en) 1998-11-03
AU690162B2 (en) 1998-04-23
CN1107703A (zh) 1995-09-06
NO944920D0 (no) 1994-12-19
IL112040A0 (en) 1995-03-15
US5574048A (en) 1996-11-12
GR3036977T3 (en) 2002-01-31
HU9403665D0 (en) 1995-02-28
AU8155094A (en) 1995-06-29
DE69427807T2 (de) 2001-12-06
EP0659414A2 (en) 1995-06-28
DE69427807D1 (de) 2001-08-30
NZ270171A (en) 1996-08-27
DK0659414T3 (da) 2001-09-24
EP0659414B1 (en) 2001-07-25
KR950016728A (ko) 1995-07-20
ATE203406T1 (de) 2001-08-15
JPH07215864A (ja) 1995-08-15
CZ321394A3 (en) 1995-08-16
ZA9410092B (en) 1996-06-19
PT659414E (pt) 2001-11-30
US5686468A (en) 1997-11-11
RU94044457A (ru) 1996-10-10
ES2157961T3 (es) 2001-09-01
HUT71479A (en) 1995-11-28

Similar Documents

Publication Publication Date Title
ZA9410084B (en) Methods of inhibiting thrombin
GR3036971T3 (en) Methods for inhibiting endometriosis.
NO943878D0 (no) Hemming av uterinfibrose
IL112042A0 (en) Methods of inhibiting seborrhea and acne
IL111289A0 (en) Methods for inhibiting angiogenesis and angiogenic diseases
NO944925D0 (no) Fremgangsmåte for å öke libido i post-menopausale kvinner
NO944929L (no) Fremgangsmåte for å inhibere CNS-problemer i post-menopausale kvinner
NO944920L (no) Fremgangsmåte for å inhibere hirsutisme og alopecia hos kvinner